申请人:Repros Therapeutics Inc.
公开号:EP2826475A1
公开(公告)日:2015-01-21
The present invention relates to the administration of compositions comprising an antiestrogen, preferably trans-clomiphene, for treating metabolic syndrome in a subject. The invention is also directed to methods for reducing fasting glucose levels in a subject by administering a composition comprising an antiestrogen, preferably trans-clomiphene.
本发明涉及施用包含抗雌激素(最好是反式-克罗米芬)的组合物治疗受试者的代谢综合征。本发明还涉及通过施用包含抗雌激素(最好是反式-氯米芬)的组合物来降低受试者空腹血糖水平的方法。